Shingles Vaccine Linked to 9 Percent Lower Cardiovascular Disease Risk, New Study Finds
New research finds that the Shingrix shingles vaccine is associated with a 9 percent reduction in cardiovascular disease risk. A separate study found that a tailored exercise program can cut atrial fibrillation recurrence by 45 percent.
A new study has found that the Shingrix shingles vaccine is associated with a 9 percent reduction in cardiovascular disease risk. The finding adds to growing evidence that vaccines may offer health benefits beyond their primary target.
Shingrix, made by GSK, is already recommended for adults 50 and older to prevent shingles and its complications, including postherpetic neuralgia. Researchers believe the cardiovascular benefit may be linked to the vaccine's effect on inflammation, since shingles infections are known to temporarily raise the risk of heart attack and stroke.
In a separate development, a study published this month found that a tailored exercise program can reduce atrial fibrillation recurrence by 45 percent. Atrial fibrillation, the most common heart rhythm disorder, affects millions of Americans and significantly raises stroke risk.
The exercise program in the study was individualized based on each patient's fitness level and health history, rather than following a one-size-fits-all protocol. Researchers say the results support adding structured physical activity to standard atrial fibrillation treatment plans.
Both findings were highlighted in September 2026 health news roundups from Healthline and the Global Wellness Institute. Doctors caution that patients should discuss any changes to their vaccination or exercise plans with their healthcare provider.
